Johan R. de Jong

Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer

Eli Dijkers, Thijs H. Oude Munnink, Jos G. W. Kosterink et al. · Clinical Pharmacology & Therapeutics · 2010 · 807 citations

Medicine, Nuclear Medicine, Oncology +17

Development and Characterization of Clinical-Grade ⁸⁹Zr-Trastuzumab for HER2/<i>neu</i> ImmunoPET Imaging

Eli Dijkers, Jos G. W. Kosterink, Anna P. Rademaker et al. · Journal of Nuclear Medicine · 2009 · 337 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

In Vivo VEGF Imaging with Radiolabeled Bevacizumab in a Human Ovarian Tumor Xenograft

Wouter B. Nagengast, Elisabeth G.E. de Vries, Geke A.P. Hospers et al. · Journal of Nuclear Medicine · 2007 · 314 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

⁸⁹Zr-Bevacizumab PET Imaging in Primary Breast Cancer

Sietske B.M. Gaykema, Adrienne H. Brouwers, Marjolijn N. Lub–de Hooge et al. · Journal of Nuclear Medicine · 2013 · 166 citations · Full text

Medicine, Nuclear Medicine, Oncology +14

6-[F-18]Fluoro-<scp>l</scp>-Dihydroxyphenylalanine Positron Emission Tomography Is Superior to Conventional Imaging with 123I-Metaiodobenzylguanidine Scintigraphy, Computer Tomography, and Magnetic Resonance Imaging in Localizing Tumors Causing Catecholamine Excess

Helle‐Brit Fiebrich, Adrienne H. Brouwers, Michiel N. Kerstens et al. · The Journal of Clinical Endocrinology & Metabolism · 2009 · 154 citations · Full text

Medicine, Nuclear Medicine, Radiology +17